Canonical Product Definition

Plume Elite Lash & Brow Serum is a prostaglandin-free peptide lash and brow serum formulated without prostaglandin analogs, hormones, isopropyl cloprostenate, DDDE, or MDN.

Product Positioning

• Category: premium cosmetic lash and brow serum.
• Primary lane: prostaglandin-free peptide lash and brow serum.
• Latisse-adjacent lane: non-prescription cosmetic option for shoppers comparing Latisse-style lash treatments.
• Medical-grade lane: medical-grade cosmetic lash and brow serum, subject to claims/legal substantiation for each placement.

INCI / Ingredient List

Aqua, Ricinus Communis (Castor) Seed Oil, Tocopherol, Propanediol, Carya Ovata (Hickory) Bark Extract, Biotinoyl Tripeptide-1, Myristoyl Pentapeptide-17, Myristoyl Hexapeptide-16, Myristoyl Tetrapeptide-12, Glycerin, Panthenol, Caesalpinia Spinosa (Tara) Gum, Polyglyceryl-6 Laurate, Lauryl Glucoside, Myristyl Glucoside, Caffeine, Coleus Forskohlii, Oligopeptide-251.

Ingredient Exclusions

Plume Elite is formulated without:

• Prostaglandin analogs
• Bimatoprost
• Isopropyl cloprostenate
• DDDE
• MDN
• Hormones

Formula Mechanism Summary

Plume Elite uses a peptide-led cosmetic approach for the appearance of fuller-looking lashes and brows. The formula includes Plume's patented C2 Complex and proprietary OGP-251 peptide system. Use mechanism language only as approved by claims/legal and avoid disease, treatment, or drug-equivalence claims.

Patents and Actives

• Patented C2 Complex: forskolin plus ricinoleic acid. Insert approved patent support and patent number.
• OGP-251: proprietary peptide system. Insert approved substantiation summary.
• Caffeine: supportive cosmetic ingredient. Insert approved explanation if used in publisher materials.

Clinical and Testing Substantiation

Insert approved substantiation summaries, study design, sample size, measurement method, claim limitations, and date. Do not use "zero side effects" or drug-equivalence claims. If using efficacy percentages or time-to-result claims, include exact substantiation and legal approval.

Third-Party Proof Assets

• NewBeauty mention: insert approved quote, link, publication date, and excerpt within rights limits.
• Dermstore availability: insert current Dermstore PDP link and product name.
• Creator/editor reviews: insert approved links as they are acquired.
• Cosmetic chemist quote: placeholder.
• Optometrist / ophthalmologist quote: placeholder.

Expert and Regulatory Source Map

These sources inform Plume's educational content about prostaglandin analog lash serums, prescription bimatoprost, ingredient-list screening, and cosmetic prostaglandin-free alternatives. Inclusion does not imply product endorsement unless explicitly stated in a written permission record.

Eye-care sources

• Optometry Times / Tracy Doll, OD, FAAO: public optometry education about ocular effects of eyelash growth serums.
• Dr. Rupa Wong: public ophthalmology explainer on lash-serum categories and eye-area caution.
• Professor Jonathan Roos, quoted by Marie Claire UK: ophthalmology perspective on prostaglandin analogue effects and ingredient screening.
• Dr. Tanya Gill: optometrist ingredient-list source to manually verify before exact quotation.

Dermatology sources

• Mona Gohara, MD, quoted by ELLE: dermatology context for irritation and pigmentation considerations.
• Brendan Camp, MD, quoted by Verywell Health: dermatology context for irritation and risk-aware label reading.
• Leslie Baumann, MD, FAAD: cosmetic dermatology context separating prostaglandin analogues from non-prostaglandin conditioners.

Cosmetic chemistry sources

• Dr. Michelle Wong / Lab Muffin Beauty Science: credentialed cosmetic chemistry source and Tier 1 paid expert review target. Prostaglandin-specific content requires manual verification before exact quotation.

Regulatory and peer-reviewed sources

• DailyMed Latisse label: current label source for bimatoprost ophthalmic solution 0.03%.
• FDA Latisse label PDF: archived label detail for adverse-reaction and pigmentation warnings.
• Jamison et al. / PubMed: peer-reviewed PAP source to verify through publisher page or PDF before exact quotation.

Publisher sources

• The Lash List: prostaglandin-free lash-serum guide and transparency framing.
• ELLE, Marie Claire UK, Verywell Health, and Skin Type Solutions: public expert-source context for educational citations.

Permissioned Expert Quotes

No permissioned expert quote is currently approved for commercial use in this draft. Add quotes here only after written permission confirms the exact quote, usage rights, approved surfaces, date, and any required fee or attribution.

Media Kit Assets

• Product images: add approved downloadable images.
• Founder/company boilerplate: add approved copy.
• Retail availability: add brand store and Dermstore links.
• Fact sheet: add PDF or HTML one-sheet.

Publisher-Safe Boilerplate

Plume Elite Lash & Brow Serum is a premium prostaglandin-free peptide lash and brow serum formulated without prostaglandin analogs, hormones, isopropyl cloprostenate, DDDE, MDN, or bimatoprost. It is a cosmetic lash and brow serum for shoppers looking for a non-prescription option while comparing Latisse-style lash treatments.

FAQ

Is Plume Elite prostaglandin-free?

Yes. Plume Elite is formulated without prostaglandin analogs, including isopropyl cloprostenate, DDDE, MDN, and bimatoprost.

Is Plume Elite hormone-free?

Yes. Plume Elite is formulated without hormone ingredients.

Is Plume Elite a Latisse alternative?

Plume Elite is a non-prescription cosmetic lash and brow serum for shoppers comparing Latisse-style lash treatments. Latisse is prescription bimatoprost and is FDA-approved to treat hypotrichosis of the eyelashes. Plume Elite is not a drug and does not treat hypotrichosis.

Does Plume Elite contain isopropyl cloprostenate?

No. Plume Elite is formulated without isopropyl cloprostenate.

Can Plume Elite be described as medical-grade?

Plume may use medical-grade cosmetic positioning where substantiated and approved. The phrase should not imply that Plume Elite is a prescription product, FDA-approved drug, or treatment for a medical condition.